John Breitner was recruited to the Douglas to lead a new Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD). The Centre seeks measurement and detection of change in biomarkers thought to reveal the progress of presymptomatic Alzheimer’s disease. With such ability to measure change, the Centre undertakes clinical trials for Pre-symptomatic Evaluation of Novel or Experimental Treatments for AD (PREVENT-AD).
John Breitner has authored over 200 publications and has mentored more than 15 doctoral and post-doctoral students, almost all of whom have gone on to hold full-time academic appointments.
Pierre Bellec, PhD